Citations

Institution: Mayo Clinic Clear

Showing 10 of 108083 citations.

Behind closed doors: a look into hospital-at-home antimicrobial use
Dickinson, Drew T. , Ilges, Dan , Maniaci, Michael J. , Maniaci, Michael J , Ilges, Dan

Infection Control & Hospital Epidemiology | August 19, 2025 | Volume: 46 | Issue: 9 | Pages: 948-950

10.1017/ice.2025.10244 | PMID 40826926 Get It

Abstract Antimicrobial use among hospital-at-home (HaH) patients across three Mayo Clinic sites was evaluated from 2023 to 2024. Nearly three-quarters of patients were administered an antibiotic during HaH admission. Ceftriaxone was the most commonly used antibiotic and respiratory infections were the most common antimicrobial indication. Further investigation into stewardship opportunities is warranted.
Uncover This Tech Term: Agentic Artificial Intelligence in Radiology
Faghani, Shahriar , Moassefi, Mana , Rouzrokh, Pouria , Khosravi, Bardia , Erickson, Bradley J. , Khosravi, Bardia , Erickson, Bradley J , Rouzrokh, Pouria , Faghani, Shahriar , Moassefi, Mana

Korean Journal of Radiology | August 19, 2025 | Volume: 26 | Issue: 9 | Pages: 888

10.3348/kjr.2025.0370 | PMID 40873379 Get It

Guidelines Recommending That Clinicians Advise Patients on Lifestyle Changes
Johansson, Minna , Niklasson, Amanda , Albarqouni, Loai , Jørgensen, Karsten Juhl , Guyatt, Gordon, Montori, Víctor M. , Montori, Victor M

Annals of Internal Medicine | August 18, 2025 | Volume: 178 | Issue: 8 | Pages: 1215

10.7326/annals-25-01852 | PMID 40825212 Get It

What Is the Potential Relevance of Growth and Differentiation Factor-15 in Neurologic Disease?
Benarroch, Eduardo E. , Benarroch, Eduardo

Neurology | August 18, 2025 | Volume: 105 | Issue: 5 | Pages: No page available

10.1212/wnl.0000000000214131 | PMID 40825163 Get It

Alzheimer Disease Treatments and Co-Pathologies
Petersen, Ronald C.

Neurology | August 18, 2025 | Volume: 105 | Issue: 5 | Pages: No page available

10.1212/wnl.0000000000214061 | PMID 40825159 Get It

Cognitive and behavioral therapies for insomnia: must they always be in bed together?
Gugliotta, Alessio A., Gorovoy, Suzanne , Kolla, Bhanu Prakash , Grandner, Michael A. , Ellis, Jason Gordon , Bastien, Célyne , Fox, Rina S.

Journal of Clinical Sleep Medicine | August 18, 2025 | Volume: 21 | Issue: 10 | Pages: 1655-1657

10.5664/jcsm.11862 | PMID 40820607 Get It

Long-Term Survival After Surgical Resection for Rectal Cancer Is Associated With Textbook Outcome but Not Surgical Case Volume
Aly, Mohamed R., Stucky, Chee-Chee, Etzioni, David A. , Wasif, Nabil , Etzioni, David, Chang, Yu‐Hui , Fong, Zhi Ven

Annals of Surgery Open | August 18, 2025 | Volume: 6 | Issue: 3 | Pages: e601

10.1097/as9.0000000000000601 | PMID 40989869 Get It

Objective: Analyzing textbook outcome (TO) following rectal cancer resection and its association with long-term survival when compared to hospital case volume alone. Background: TO is a quality metric representing the ideal result following complex cancer surgery. Prior studies have suggested improved long-term survival for rectal cancer patients undergoing surgery at HV institutions. Methods: Patients undergoing surgery for rectal adenocarcinoma from 2014 to 2015 were identified using the National Cancer Database. Low (LV), medium (MV), and high-volume (HV) hospital strata were defined by quartile cutoffs (low <25th, high >75th, and 25–75th medium volume). TO was achieved with adequate lymph node count (≥12), negative margins (R0 resection), length of stay <75th percentile, absence of 30-day readmission/mortality event, and appropriate plus timely systemic therapy. Adjusted analyses for long-term survival were performed using a hierarchical multivariable Cox regression model. Results: TO was achieved in 28.5% of 48,484 patients. LV or MV hospital patients were more likely to be older, uninsured/Medicaid, and less likely to achieve a TO (HV 31.2% vs MV 29.6% vs LV 23.2%, P < 0.001). TO was associated with improved 5-year survival (84.0% vs 72.0%, P < 0.001). On multivariable analyses, TO was the strongest protective factor against mortality (HR 0.60, 95% confidence interval = 0.56–0.64), even after controlling for case volume. Conclusions: Only 28.5% of patients undergoing resection for rectal cancer achieve TO. However, they had a 40% reduction in long-term mortality independent of hospital volume. Optimizing long-term survival in patients with rectal cancer can be achieved by TO criteria rather than increasing surgical case volume.
Application of Platelet-Rich Plasma in Gynaecologic Disorders: A Scoping Review
Willison, Nadia , Aryan, Pouria , Damabi, Negin Mirzaei, Nguyen, Tran , Yi, Johnny , Dutta, Rituparna, Aryan, Pouria , Padhani, Zahra Ali , Abbott, Derek , Behnia‐Willison, Fariba , Damabi, Negin Mirzaei, Dutta, Rituparna

Journal of Clinical Medicine | August 18, 2025 | Volume: 14 | Issue: 16 | Pages: 5832

10.3390/jcm14165832 | PMID 40869658 Get It

Platelet-rich plasma (PRP) therapy is a non-invasive, autologous treatment with regenerative potential in gynaecology beyond fertility applications. This review evaluates PRP in non-fertility-related gynaecological conditions affecting women’s quality of life (QoL). Methods: Following PRISMA-ScR guidelines, we searched Embase, CINAHL, Web of Science, Scopus, CENTRAL, and MEDLINE for studies on PRP in conditions such as vulvar lichen sclerosus (VLS), vulvovaginal atrophy (VVA), sexual dysfunction (SD), stress urinary incontinence (SUI), and interstitial cystitis/bladder pain syndrome (IC/BPS). Of 3660 records screened, 43 studies (randomised controlled trials, quasi-experimental, cohort, and case series) were included. Results: PRP improved symptoms and QoL in several conditions, particularly VLS and SD, and was generally well tolerated with minor adverse effects (e.g., injection-site pain, transient discomfort). Evidence for abnormal uterine bleeding (AUB) and pelvic organ prolapse (POP) was inconclusive. Considerable heterogeneity in preparation protocols and outcome measures limited cross-study comparison. Conclusions: PRP shows promise as a minimally invasive therapy for certain gynaecological conditions. Standardisation of preparation and administration, along with large-scale RCTs, is needed to determine long-term efficacy and safety.
Advancements in Inlay Glenoid Components for Anatomic Total Shoulder Arthroplasty: A Review
Reddy, Akshay , Hones, Keegan M. , Rakauskas, Taylor R. , King, Joseph J. , Wright, Thomas W., Hao, Kévin A. , Reddy, Akshay R , Hao, Kevin A , King, Joseph J , Hones, Keegan M , Wright, Thomas W. , Schoch, Bradley S.

Journal of Clinical Medicine | August 18, 2025 | Volume: 14 | Issue: 16 | Pages: 5820

10.3390/jcm14165820 | PMID 40869646 Get It

While anatomic total shoulder arthroplasty is a successful procedure that provides reliable pain relief and restoration of function in most patients, its success has been limited by glenoid component loosening. While series reporting the outcomes of inlay glenoid components have demonstrated excellent clinical outcomes with low rates of component loosening and need for revision, surgeons have been hesitant to adopt these implants due to concerns of inadequate pain relief secondary to the remaining glenoid rim contacting the humeral head implant. The inset glenoid component, a variant of the traditional inlay components, has gained interest because its design aims to achieve similar stability to traditional inlay components through implantation within strong subchondral bone, reduce the amount of glenoid vault removed compared to inlay components, and has a glenoid face designed to limit the rocking-horse phenomenon. In limited series, the inset glenoid component has demonstrated superior biomechanical and clinical performance compared to traditional onlay glenoid components. Although there have been minimal clinical studies investigating the inset glenoid in comparison to onlay and inlay components to date, a subset of case series with short-term follow-up have demonstrated favorable outcomes. The purpose of this article was to review the design rationale, biomechanical evidence, and clinical performance of the inset glenoid component.
Symptom Burden in Adolescents and Young Adults With Cancer
Ruddy, Kathryn J. , Pachman, Deirdre R. , Kour, Oudom, Grzegorczyk, Veronica , Ehlers, Shawna L. , Cobran, Ewan K. , Greenmyer, Jacob R. , Lam, Veronica , Ehlers, Shawna , Storandt, Michael H. , Jin, Zhaohui , Kroenke, Kurt , Griffin, Joan M. , Austin, Jessica D. , Mitchell, Sandra A , Smith, Ashley Wilder , Chlan, Linda L. , Allen‐Rhoades, Wendy , Shi, Qian , Cheville, Andrea

JAMA Network Open | August 18, 2025 | Volume: 8 | Issue: 8 | Pages: e2527421

10.1001/jamanetworkopen.2025.27421 | PMID 40824642 Get It

This cross-sectional study analyzes patient-reported outcome findings from the Enhanced, Electronic Health Record–Facilitated Cancer Symptom Control (E2C2) trial to investigate level of symptom burden in adolescents and young adults with cancer.